The Third Histamine Receptor 2008
DOI: 10.1201/9781420053937.ch6
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral Actions and Therapeutic Potential in Periphery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
4
0

Year Published

2010
2010
2012
2012

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 252 publications
1
4
0
Order By: Relevance
“…In particular, the involvement of H 3 Rs was ruled out based on the ineffectiveness of the H 3 R antagonist clobenpropit. As opposed to the study by Konturek et al [30] , our data clearly suggest that histamine released by ghrelin activates H 3 Rs to afford protective effects, in accordance with literature data [31][32][33][34] . The reason for this discrepancy may possibly be attributed to the use of clobenpropit; indeed, it has recently been demonstrated that this compound, originally described as a potent and highly selective H 3 R antagonist [35] , also displays affinity for the newly discovered H 4 R, behaving as a partial agonist in functional assays [36] .…”
Section: Discussionsupporting
confidence: 90%
See 2 more Smart Citations
“…In particular, the involvement of H 3 Rs was ruled out based on the ineffectiveness of the H 3 R antagonist clobenpropit. As opposed to the study by Konturek et al [30] , our data clearly suggest that histamine released by ghrelin activates H 3 Rs to afford protective effects, in accordance with literature data [31][32][33][34] . The reason for this discrepancy may possibly be attributed to the use of clobenpropit; indeed, it has recently been demonstrated that this compound, originally described as a potent and highly selective H 3 R antagonist [35] , also displays affinity for the newly discovered H 4 R, behaving as a partial agonist in functional assays [36] .…”
Section: Discussionsupporting
confidence: 90%
“…In parallel experiments, the selective H 3 R agonist, immethridine (30 mg/kg s.c.) was tested against 0.6 N HCl-induced gastric damage in the absence or in the presence of UCL2138 or the ghrelin receptor antagonist, [ D -Lys 3 ]-GHRP-6 (100 g/kg i.p.). The dose of immethridine was chosen on the basis of previous experiments [31] as the dose inducing the maximum protective effects against 0.6 N HCl. Stomachs were evaluated for the presence of macroscopic gastric lesions according to the method above described.…”
Section: Involvement Of H 3 Rs In the Protective Effect Of Ghrelin Agmentioning
confidence: 99%
See 1 more Smart Citation
“…The major role of histamine and of H 2 Rs in the stomach is the regulation of acid secretion by the parietal (39,40,43,55); however, functional data were dependent on the species and the experimental assay (40,44,46). The negative regulation of histamine release from ECL cells has been proposed by several authors as the main function mediated by H 3 Rs in the rat stomach (33,43).…”
Section: Gastric Acid Secretionmentioning
confidence: 99%
“…In the recent years, it has become apparent that intestinal mast cell mediators and enteric nervous system are key players in the intricate neuroimmune network, that regulates intestinal homeostasis and the inflammatory response to noxious stimuli (90). Histamine can influence neurotransmission at both submucous and myenteric plexus, thereby modifying intestinal secretion and motility, through the activation of the three receptors H 1 , H 2 and H 3 (32,39,45,46,(91)(92)(93). The occurrence of a new receptor subtype in the intestine was firstly hypothesized by Schworer et al (94), who identified in the porcine small intestine an H 3 -like receptor Figure 2.…”
Section: Intestinal Motility and Secretionmentioning
confidence: 99%